GSK3B and type 2 diabetes mellitus: As expected, the level of p-GSK-3β was markedly lowered in T2D mice than that of the control mice, and 8-week administration of GHP increased the level of p-GSK-3β as compared with the T2D group, indicating that GSK-3β was deactivated.